The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...

Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...

Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...

Please provide your email address to receive an email when new articles are posted on . Significantly fewer pediatric patients with low- vs. high-risk intermittent asthma had an ED visit and inhaled ...

One guideline focuses on managing severe asthma and the other begins with recommendations for mild intermittent asthma before increasing based on disease severity, noted Megan Althoff, MD, PhD, ...

Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysis AstraZeneca’s inhaled anti-inflammatory rescue medication AIRSUPRA demonstrated ...

The classifications of severity are intermittent, mild-persistent, moderate-persistent, and severe-persistent (there is no longer a mild-intermittent classification). This change was made to emphasize ...

The wheezing. The coughing. The extreme and sudden shortness of breath. These are symptoms that are attached to asthma, which is a surprisingly common condition. According to the Asthma and Allergy ...

In many patients, annual short-acting beta2-agonist prescription fulfillment is indicative of uncontrolled disease and increased incidence of exacerbations. Credit: Getty Images. Short-acting beta ...

I am silently slipping into oblivion; it feels like my lungs have suddenly suffered a traffic jam; I can’t breathe properly, is this happening again? I am in pain and there is no one to help me get my ...

Asthma Awareness Month is observed every May. Asthma is a chronic lung disease that can cause wheezing, breathlessness, tightness in the chest, and coughing. According to the American Lung Association ...